Omicron Weighs On Edwards Lifesciences In The Fourth Quarter — So, What's Next?
The omicron variant weighed on Edwards Lifesciences (EW) in late 2021, leading to a fourth-quarter miss and pushing EW stock into a tumble Thursday.XFurther, Edwards issued lighter-than-expected guida...